Angiogenesis

, Volume 10, Issue 1, pp 1–11 | Cite as

CCN family proteins and angiogenesis: from embryo to adulthood

Review

Abstract

The CCN family is a novel class of extracellular signal modulators that has been recently established. Typical members are composed of four conserved modules connected tandem, each of which is rich in cysteines and highly interactive with other molecules. The mammalian CCN family consists of six members, most of which have been described as multifunctional factors for the developmental process of mesenchymal tissue including blood vessel formation/induction. Particularly, the angiogenic properties of the three classical members, CCN1, 2 and 3 have so far been characterized, and their physiological and pathological significance has thus been indicated. Recent research has uncovered a unique mechanism regarding these proteins in promoting and/or modulating developmental, physiological and pathological angiogenic events. Namely, CCN proteins exert their ability to drive angiogenesis, not by stimulating a particular behavior of a particular type of cells, but by manipulating the cell communication networks that integrate most of the associated molecules/cells toward angiogenesis. In this article, the role of the CCN proteins in a variety of angiogenic events as an organizer of microenvironmental cell society is comprehensively described, together with a brief summary of the recent findings on each CCN family member relevant to angiogenesis including cardiovascular development and diseases.

Keywords

Angiogenesis Cardiovascular development CCN family Connective tissue growth factor CTGF Cyr61 Metastasis NOV 

Notes

Acknowledgments

This work was supported by Grants-in-Aid for Scientific Research (S)(M.T.) and (C)(S.K.), for Exploratory Research (M.T) from Ministry of Education, Culture, Sports, Science and Technology of Japan and Japan Society for the Promotion of Science; the Kurozumi Medical Foundation (S. K.); the Foundation for Growth Science in Japan (M. T.); the Sumitomo Foundation (M. T.); and the Foundation of Sanyo Broadcasting (S. K.). We also thank Ms. Yuki Nonami for her valuable secretarial assistance.

References

  1. 1.
    Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438:932–936PubMedCrossRefGoogle Scholar
  2. 2.
    Coultas L, Chawengsaksophak K, Rossant J (2005) Endothelial cells and VEGF in vascular development. Nature 438:937–945PubMedCrossRefGoogle Scholar
  3. 3.
    Ribatti D (2005) The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review. Br J Haematol 128:303–309PubMedCrossRefGoogle Scholar
  4. 4.
    Bork P (1993) The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 327:125–130PubMedCrossRefGoogle Scholar
  5. 5.
    Lau LF, Lam SC (1999) The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 248:44–57PubMedCrossRefGoogle Scholar
  6. 6.
    Perbal B (2004) CCN proteins: multifunctional signalling regulators. Lancet 363:62–64PubMedCrossRefGoogle Scholar
  7. 7.
    Perbal B, Takigawa M (eds) (2005) CCN proteins—a new family of cell growth and differentiation regulators. Imperial College Press, LondonGoogle Scholar
  8. 8.
    Takigawa M, Nakanishi T, Kubota S, Nishida T (2003) Role of CTGF/HCS24/ecogenin in skeletal growth control. J Cell Physiol 194:256–266PubMedCrossRefGoogle Scholar
  9. 9.
    O’Brien TP, Yang GP, Sanders L, Lau LF (1990) Expression of cyr61, a growth factor-inducible immediate-early gene. Mol Cell Biol 10:3569–3577PubMedGoogle Scholar
  10. 10.
    Bradham DM, Igarashi A, Potter RL, Grotendorst GR (1991) Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114:1285–1294PubMedCrossRefGoogle Scholar
  11. 11.
    Joliot V, Martinerie C, Dambrine G et al (1992) Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol 12:10–21PubMedGoogle Scholar
  12. 12.
    Hashimoto Y, Shindo-Okada N, Tani M et al (1998) Expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61/Cef10, and neuroblastoma overexpressed gene) family, suppresses in vivo tumor growth and metastasis of K-1735 murine melanoma cells. J Exp Med 187:289–296PubMedCrossRefGoogle Scholar
  13. 13.
    Zhang R, Averboukh L, Zhu W et al (1998) Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation. Mol Cell Biol 18:6131–6141PubMedGoogle Scholar
  14. 14.
    Kumar S, Hand AT, Connor JR et al (1999) Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions. J Biol Chem 274:17123–17131PubMedCrossRefGoogle Scholar
  15. 15.
    Pennica D, Swanson TA, Welsh JW et al (1998) WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci USA 95:14717–14722PubMedCrossRefGoogle Scholar
  16. 16.
    Brigstock DR, Goldschmeding R, Katsube KI et al (2003) Proposal for a unified CCN nomenclature. Mol Pathol 56:127–128PubMedCrossRefGoogle Scholar
  17. 17.
    Abreu JG, Ketpura NI, Reversade B, De Robertis EM (2002) Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4:599–604PubMedGoogle Scholar
  18. 18.
    Babic AM, Chen CC, Lau LF (1999) Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 19:2958–2966PubMedGoogle Scholar
  19. 19.
    Desnoyers L, Arnott D, Pennica D (2001) WISP-1 binds to decorin and biglycan. J Biol Chem 276:47599–47607PubMedCrossRefGoogle Scholar
  20. 20.
    Inoki I, Shiomi T, Hashimoto G et al (2002) Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J 16:219–221PubMedGoogle Scholar
  21. 21.
    Jedsadayanmata A, Chen CC, Kireeva ML et al (1999) Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3). J Biol Chem 274:24321–24327PubMedCrossRefGoogle Scholar
  22. 22.
    Sakamoto K, Yamaguchi S, Ando R et al (2002) The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with Notch1 extracellular domain and inhibits myoblast differentiation via Notch signaling pathway. J Biol Chem 277:29399–29405 PubMedCrossRefGoogle Scholar
  23. 23.
    Schober JM, Chen N, Grzeszkiewicz TM et al (2002) Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. Blood 99:4457–4465PubMedCrossRefGoogle Scholar
  24. 24.
    Segarini PR, Nesbitt JE, Li D et al (2001) The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem 276:40659–40667PubMedCrossRefGoogle Scholar
  25. 25.
    Wahab NA, Weston BS, Mason RM (2005) Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA. J Am Soc Nephrol 16:340–351PubMedCrossRefGoogle Scholar
  26. 26.
    Asano M, Kubota S, Nakanishi T et al (2005) Effect of connective tissue growth factor (CCN2/CTGF) on proliferation and differentiation of mouse periodontal ligament-derived cells. Cell Commun Signal 5:11CrossRefGoogle Scholar
  27. 27.
    Brigstock DR (2002) Regulation of angiogenesis and endothelial cell function by connective growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis 5:153–165PubMedCrossRefGoogle Scholar
  28. 28.
    Gao R, Brigstock DR (2004) Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem 279:8848–8855PubMedCrossRefGoogle Scholar
  29. 29.
    Igarashi A, Okochi H, Bradham DM, Grotendorst GR (1993) Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4:637–645PubMedGoogle Scholar
  30. 30.
    Kireeva ML, Latinkic BV, Kolesnikova TV et al (1997) Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp Cell Res 233:63–77PubMedCrossRefGoogle Scholar
  31. 31.
    Nakanishi T, Nishida T, Shimo T et al (2000) Effects of CTGF/Hcs24, a product of a hypertrophic chondrocyte-specific gene, on the proliferation and differentiation of chondrocytes in culture. Endocrinology 141:264–273PubMedCrossRefGoogle Scholar
  32. 32.
    Nishida T, Nakanishi T, Asano M et al (2000) Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J Cell Physiol 184:197–206PubMedCrossRefGoogle Scholar
  33. 33.
    Safadi FF, Xu J, Smock SL et al (2003) Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. J Cell Physiol 196:51–62PubMedCrossRefGoogle Scholar
  34. 34.
    Hishikawa K, Oemar BS, Tanner FC et al (1999) Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem 274:37461–37466PubMedCrossRefGoogle Scholar
  35. 35.
    Kang Y, Siegel PM, Shu W et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537–549PubMedCrossRefGoogle Scholar
  36. 36.
    Kondo S, Kubota S, Shimo T et al (2002) Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 23:769–776PubMedCrossRefGoogle Scholar
  37. 37.
    Kubo M, Kikuchi K, Nashiro K et al (1998) Expression of fibrogenic cytokines in desmoplastic malignant melanoma. Br J Dermatol 139:192–197PubMedCrossRefGoogle Scholar
  38. 38.
    Moritani NH, Kubota S, Nishida T et al (2003) Suppressive effect of overexpressed connective tissue growth factor on tumor cell growth in a human oral squamous cell carcinoma-derived cell line. Cancer Lett 192:205–214PubMedCrossRefGoogle Scholar
  39. 39.
    Shimo T, Nakanishi T, Nishida T et al (2001) Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis. Oncology 61:315–322PubMedCrossRefGoogle Scholar
  40. 40.
    Soon LL, Yie TA, Shvarts A et al (2003) Overexpression of WISP-1 down-regulated motility and invasion of lung cancer cells through inhibition of Rac activation. J Biol Chem 278:11465–11470PubMedCrossRefGoogle Scholar
  41. 41.
    Tanaka S, Sugimachi K, Saeki H et al (2001) A novel variant of WISP1 lacking a Von Willebrand type C module overexpressed in scirrhous gastric carcinoma. Oncogene 20:5525–5532PubMedCrossRefGoogle Scholar
  42. 42.
    Tanaka S, Sugimachi K, Shimada M et al (2002) Variant WISPs as targets for gastrointestinal carcinomas. Gastroenterology 123:392–393PubMedCrossRefGoogle Scholar
  43. 43.
    Tanaka S, Sugimachi K, Kameyama T et al (2003) Human WISP1v, a member of the CCN family, is associated with invasive cholangiocarcinoma. Hepatology 37:1122–1129PubMedCrossRefGoogle Scholar
  44. 44.
    Tong X, Xie D, O’Kelly J et al (2001) Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem 276:47709–47714PubMedCrossRefGoogle Scholar
  45. 45.
    Xie D, Nakachi K, Wang H et al (2001) Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 61:8917–8923PubMedGoogle Scholar
  46. 46.
    Chen CC, Chen N, Lau LF (2001) The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem 276:10443–10452PubMedCrossRefGoogle Scholar
  47. 47.
    Lin CG, Leu SJ, Chen N et al (2003) CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem 278:24200–24208PubMedCrossRefGoogle Scholar
  48. 48.
    Shimo T, Nakanishi T, Kimura Y et al (1998) Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells. J Biochem (Tokyo) 124:130–140Google Scholar
  49. 49.
    Shimo T, Nakanishi T, Nishida T et al (1999) Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem (Tokyo) 126:137–145Google Scholar
  50. 50.
    Hoshijima M, Hattori T, Inoue M et al (2006) CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1. FEBS Lett 20:580:1376–1382Google Scholar
  51. 51.
    Nishida T, Kubota S, Fukunaga T et al (2003) CTGF/Hcs24, hypertrophic chondrocyte-specific gene product, interacts with perlecan in regulating the proliferation and differentiation of chondrocytes. J Cell Physiol 196:265–275PubMedCrossRefGoogle Scholar
  52. 52.
    Brigstock DR, Steffen CL, Kim GY et al (1997) Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor. J Biol Chem 272:20275–20282PubMedCrossRefGoogle Scholar
  53. 53.
    Kubota S, Eguchi T, Shimo T et al (2001) Novel mode of processing and secretion of connective tissue growth factor/ecogenin (CTGF/Hcs24) in chondrocytic HCS-2/8 cells. Bone 29:155–161PubMedCrossRefGoogle Scholar
  54. 54.
    Hinton DR, Spee C, He S et al (2004) Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy. Diabetes Care 27:758–764PubMedGoogle Scholar
  55. 55.
    Boes M, Dake BL, Booth BA et al (1999) Connective tissue growth factor (IGFBP-rP2) expression and regulation in cultured bovine endothelial cells. Endocrinology 140:1575–1580PubMedCrossRefGoogle Scholar
  56. 56.
    Ivkovic S, Yoon BS, Popoff SN et al (2003) Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130:2779–2791PubMedCrossRefGoogle Scholar
  57. 57.
    Kutz WE, Gong Y, Warman ML (2005) WISP3, the gene responsible for the human skeletal disease progressive pseudorheumatoid dysplasia, is not essential for skeletal function in mice. Mol Cell Biol 25:414–421PubMedCrossRefGoogle Scholar
  58. 58.
    Mo FE, Muntean AG, Chen CC et al (2002) CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol 22:8709–8720PubMedCrossRefGoogle Scholar
  59. 59.
    Suzuma K, Naruse K, Suzuma I et al (2000) Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J Biol Chem 275:40725–40731PubMedCrossRefGoogle Scholar
  60. 60.
    Babic AM, Kireeva ML, Kolesnikova TV, Lau LF (1998) CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 95:6355–6360PubMedCrossRefGoogle Scholar
  61. 61.
    Ginsberg MH, Partridge A, Shattil SJ (2005) Integrin regulation. Curr Opin Cell Biol 17:509–516PubMedCrossRefGoogle Scholar
  62. 62.
    Leu SJ, Lam SC, Lau LF (2002) Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J Biol Chem 277:46248–46255PubMedCrossRefGoogle Scholar
  63. 63.
    Grzeszkiewicz TM, Lindner V, Chen N et al (2002) The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans. Endocrinology 143:1441–1450PubMedCrossRefGoogle Scholar
  64. 64.
    Kolesnikova TV, Lau LF (1998) Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells. Oncogene 16:747–754PubMedCrossRefGoogle Scholar
  65. 65.
    Grotendorst GR, Duncan MR (2005) Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J 19:729–738PubMedCrossRefGoogle Scholar
  66. 66.
    Friedrichsen S, Heuer H, Christ S et al (2005) Gene expression of connective tissue growth factor in adult mouse. Growth Factors 23:43–53PubMedGoogle Scholar
  67. 67.
    Surveyor GA, Brigstock DR (1999) Immunohistochemical localization of connective tissue growth factor (CTGF) in the mouse embryo between days 7.5 and 14.5 of gestation. Growth Factors 17:115–124PubMedCrossRefGoogle Scholar
  68. 68.
    Delmolino LM, Stearns NA, Castellot JJ Jr (2001) COP-1, a member of the CCN family, is a heparin-induced growth arrest specific gene in vascular smooth muscle cells. J Cell Physiol 188:45–55PubMedCrossRefGoogle Scholar
  69. 69.
    Kleer CG, Zhang Y, Pan Q et al (2002) WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene 21:3172–3180PubMedCrossRefGoogle Scholar
  70. 70.
    Gupta N, Wang H, McLeod TL et al (2001) Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol 54:293–299PubMedCrossRefGoogle Scholar
  71. 71.
    Kondo S, Kubota S, Mukudai Y et al (2006) Hypoxic regulation of stability of connective tissue growth factor/CCN2 mRNA by 3′-untranslated region interacting with a cellular protein in human chondrosarcoma cells. Oncogene 25:1099–1110PubMedCrossRefGoogle Scholar
  72. 72.
    Kubota S, Kondo S, Eguchi T et al (2000) Identification of an RNA element that confers post-transcriptional repression of connective tissue growth factor/hypertrophic chondrocyte specific 24 (ctgf/hcs24) gene: similarities to retroviral RNA–protein interactions. Oncogene 19:4773–4786PubMedCrossRefGoogle Scholar
  73. 73.
    Kubota S, Takigawa M (2002) Driving the driver: molecular regulation of CTGF/Hcs24/CCN2 that regulates chondrocyte growth and differentiation. In Recent Research Developments in Biophysics and Biochemistry. Research Signpost, Kerala, pp 995–1012Google Scholar
  74. 74.
    Hayashi N, Kakimuma T, Soma Y et al (2002) Connective tissue growth factor is directly related to liver fibrosis. Hepatogastroenterology 49:133–135PubMedGoogle Scholar
  75. 75.
    Ito Y, Aten J, Bende RJ et al (1998) Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53:853–861PubMedCrossRefGoogle Scholar
  76. 76.
    Sawai K, Mori K, Mukoyama M et al (2003) Angiogenic protein Cyr61 is expressed by podocytes in anti-Thy-1 glomerulonephritis. J Am Soc Nephrol 14:1154–1163PubMedCrossRefGoogle Scholar
  77. 77.
    Igarashi A, Nashiro K, Kikuchi K et al (1996) Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106:729–733PubMedCrossRefGoogle Scholar
  78. 78.
    Dean RG, Balding LC, Candido R et al (2005) Connective tissue growth factor and cardiac fibrosis after myocardial infarction. J Histochem Cytochem 53:1245–1256PubMedCrossRefGoogle Scholar
  79. 79.
    Oemar BS, Werner A, Garnier JM et al (1997) Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 95:831–839PubMedGoogle Scholar
  80. 80.
    Hilfiker A, Hilfiker-Kleiner D, Fuchs M et al (2002) Expression of CYR61, an angiogenic immediate early gene, in arteriosclerosis and its regulation by angiotensin II. Circulation 106:254–260PubMedCrossRefGoogle Scholar
  81. 81.
    Cicha I, Yilmaz A, Klein M et al (2005) Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro. Arterioscler Thromb Vasc Biol 25:1008–1013PubMedCrossRefGoogle Scholar
  82. 82.
    Yoshisue H, Suzuki K, Kawabata A et al (2002) Large scale isolation of non-uniform shear stress-responsive genes from cultured human endothelial cells through the preparation of a subtracted cDNA library. Atherosclerosis 162:323–334PubMedCrossRefGoogle Scholar
  83. 83.
    Sohn M, Tan Y, Wang B et al (2006) Mechanisms of low-density lipoprotein-induced expression of connective tissue growth factor in human aortic endothelial cells. Am J Physiol Heart Circ Physiol 290:H1624–1634PubMedCrossRefGoogle Scholar
  84. 84.
    Igarashi A, Okochi H, Bradham DM, Grotendorst GR (1993) Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4:637–645PubMedGoogle Scholar
  85. 85.
    Nishida T, Kubota S, Kojima S et al (2004) Regeneration of defects in articular cartilage in rat knee joints by CCN2 (connective tissue growth factor). J Bone Miner Res 19:1308–1319PubMedCrossRefGoogle Scholar
  86. 86.
    Chen CC, Mo FE, Lau LF (2001) The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J Biol Chem 276:47329–47337PubMedCrossRefGoogle Scholar
  87. 87.
    Ferrara N, Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 438:967–974PubMedCrossRefGoogle Scholar
  88. 88.
    Aikawa T, Gunn J, Spong SM, Klaus SJ, Korc M (2006) Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer. Mol Cancer Ther 5:1108–1116PubMedCrossRefGoogle Scholar
  89. 89.
    Shimo T, Kubota S, Yoshioka N, Ibaragi S, Isowa S, Eguchi T, Sasaki A, Takigawa M (2006) Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer. J Bone Miner Res 21:1045–1059PubMedCrossRefGoogle Scholar
  90. 90.
    Kondo S, Tanaka N, Kubota S et al (2006) Novel angiogenic inhibitor DN-9693 that inhibits post-transcriptional induction of connective tissue growth factor (CTGF/CCN2) by vascular endothelial growth factor (VEGF) in human endothelial cells. Mol Cancer Therap 5:129–137CrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media B.V. 2006

Authors and Affiliations

  1. 1.Department of Biochemistry and Molecular DentistryOkayama University Graduate School of Medicine, Dentistry and Pharmaceutical SciencesOkayamaJapan

Personalised recommendations